FDA Approved Biologics: Can Etanercept and Ustekinumab be considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review – Vide Leaf

Prime Archives in Medicine: 2nd Edition

FDA Approved Biologics: Can Etanercept and Ustekinumab be considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic ReviewDownload

FDA-Approved-Biologics-Can-Etanercept-and-Ustekinumab-be-considered-a-First-Line-Systemic-Therapy-for-PediatricAdolescents-in-Moderate-to-Severe-Psoriasis-A-Syste